Tag: Teprotumumab

October 8, 2019 Off

New Data Insights from the Phase 3 Teprotumumab Trial (OPTIC) to be Presented at the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Scientific Symposium

DUBLIN–(BUSINESS WIRE)–Additional results from the Phase 3 confirmatory clinical trial (OPTIC) of teprotumumab, an investigational medicine being developed by Horizon…

April 26, 2019 Off

New Data from Phase 3 Teprotumumab Trial (OPTIC) Shows Dramatic Reduction in Proptosis, or Eye Bulging, the Main Cause of Morbidity in Active Thyroid Eye Disease (TED)

By BusinessWire

New Data at the 2019 American Association of ClinicalEndocrinologists (AACE) Scientific and Clinical Congress DemonstratesSignificant Proptosis Reduction and Improvement in Overall Response Rate